Efficient Systemic Treatment With Mesothelin-Targeted Oncolytic Adenovirus in Patient- Derived Xenograft (PDX) Model of Pancreatic Cancer

被引：0
|
作者：
Sato-Dahlman, M. [1 ]
Hajeri, P. [1 ]
Yoshida, H. [1 ]
Jacobsen, K. [1 ]
Yanagiba, C. [1 ]
Yamamoto, M. [1 ]
机构：
[1] Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA
来源：
PANCREAS | 2018年 / 47卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1421 / 1421
页数：1
相关论文
共 50 条
  • [1] Efficient Systemic Treatment with Mesothelin-Targeted Oncolytic Adenovirus in Patient-Derived Xenograft (PDX) Model of Pancreatic Cancer
    Sato-Dahlman, Mizuho
    Miura, Yoshiaki
    Hajeri, Praveensingh
    Yoshida, Hideki
    Jacobsen, Kari
    Yanagiba, Chikako
    Yamamoto, Masato
    [J]. MOLECULAR THERAPY, 2018, 26 (05) : 330 - 330
  • [2] EFFICIENT SYSTEMIC TREATMENT WITH MESOTHELIN-TARGETED ONCOLYTIC ADENOVIRUS IN PANCREATIC CANCER
    Sato-Dahlman, Mizuko
    Jacobsen, Kati
    Yanagiba, Chikako
    Yamamoto, Masato
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S469 - S469
  • [3] Systemic treatment with mesothelin-targeted oncolytic adenovirus shows efficacy patient-derived xenograft of pancreatic cancer
    Sato-Dahlman, Mizuho
    Miura, Yoshiaki
    Hajeri, Praveensingh
    Yoshida, Hideki
    Jacobsen, Kari
    Yanagiba, Chikako
    Yamamoto, Masato
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [4] SYSTEMIC TREATMENT WITH MESOTHELIN-TARGETED ONCOLYTIC ADENOVIRUS SHOWS EFFICACY PATIENT-DERIVED XENOGRAFT OF PANCREATIC CANCER
    Sato-Dahlman, Mizuho
    Miura, Yoshiaki
    Hajeri, Praveensingh
    Yoshida, Hideki
    Jacobsen, Kari
    Yanagiba, Chikako
    Yamamoto, Masato
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S517 - S517
  • [5] Efficacy of Systemic Administration of Mesothelin-Targeted Oncolytic Adenovirus In Pancreatic Cancer
    Sato-Dahlman, Mizuho
    Hajeri, Praveensingh
    Jacobsen, Kari
    Yanagiba, Chikako
    Yamamoto, Masato
    [J]. MOLECULAR THERAPY, 2021, 29 (04) : 322 - 323
  • [6] Efficacy of Systemic Administration of Mesothelin-Targeted Oncolytic Adenovirus in Pancreatic Cancer
    Sato-Dahlman, M.
    Hajeri, P.
    Jacobsen, K.
    Yanagiba, C.
    Yamamoto, M.
    [J]. PANCREAS, 2021, 50 (07) : 1095 - 1095
  • [7] Intravenous Application of Mesothelin-targeted Oncolytic Adenovirus in Pancreatic Cancer
    Sato-Dahlman, M.
    Miura, Y.
    Hajeri, P.
    Yoshida, H.
    Jacobsen, K.
    Yanagiba, C.
    Yamamoto, M.
    [J]. PANCREAS, 2019, 48 (10) : 1516 - 1516
  • [8] Intravenous Application of Mesothelin-Targeted Oncolytic Adenovirus to Pancreatic Cancer
    Sato-Dahlman, Mizuho
    Miura, Yoshiaki
    Hajeri, Praveensingh
    Yoshida, Hideki
    Jacobsen, Kari
    Yanagiba, Chikako
    Yamamoto, Masato
    [J]. MOLECULAR THERAPY, 2019, 27 (04) : 124 - 124
  • [9] Mesothelin-Targeted Infectivity Selective Oncolytic Adenovirus for Pancreatic Cancer by Redesigning the AB-loop via Adenovirus Library Screening
    Miura, Yoshiaki
    Davydova, Julia
    Yamamoto, Masato
    [J]. GASTROENTEROLOGY, 2012, 142 (05) : S329 - S329
  • [10] Efficient Systemic Treatment With Fiber-redesigned Oncolytic Adenovirus in Pancreatic Cancer In Vivo Model
    Sato-Dahlman, M.
    Miura, Y.
    Huang, J. L.
    Hajeri, P.
    Yoshida, H.
    Jacobsen, K.
    Davydova, J.
    Yamamoto, M.
    [J]. PANCREAS, 2017, 46 (10) : 1430 - 1430
12345